Payers Seek Missing Link Between Diagnostic Tests And Clinical Outcomes
• By Shirley Haley
Personalized medicine remains a worthy goal, but for payers the evidence just isn't there yet to support reimbursement of much diagnostic testing, the Tufts Center for the Study of Drug Development concludes in its July/August Impact Report.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
